Two Sigma Investments LP Cuts Stake in Oscar Health, Inc. (NYSE:OSCR)

Two Sigma Investments LP reduced its stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 53.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 707,485 shares of the company's stock after selling 818,288 shares during the period. Two Sigma Investments LP owned about 0.29% of Oscar Health worth $9,509,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently made changes to their positions in the stock. Summit Investment Advisors Inc. boosted its stake in shares of Oscar Health by 5.8% in the 4th quarter. Summit Investment Advisors Inc. now owns 20,838 shares of the company's stock valued at $280,000 after purchasing an additional 1,141 shares in the last quarter. Arizona State Retirement System boosted its stake in shares of Oscar Health by 3.1% in the 4th quarter. Arizona State Retirement System now owns 47,918 shares of the company's stock valued at $644,000 after purchasing an additional 1,454 shares in the last quarter. Xponance Inc. boosted its stake in shares of Oscar Health by 12.9% in the 4th quarter. Xponance Inc. now owns 14,394 shares of the company's stock valued at $193,000 after purchasing an additional 1,649 shares in the last quarter. KBC Group NV boosted its stake in shares of Oscar Health by 56.1% in the 4th quarter. KBC Group NV now owns 7,107 shares of the company's stock valued at $96,000 after purchasing an additional 2,555 shares in the last quarter. Finally, Alliancebernstein L.P. boosted its stake in shares of Oscar Health by 1.1% in the 4th quarter. Alliancebernstein L.P. now owns 243,160 shares of the company's stock valued at $3,268,000 after purchasing an additional 2,600 shares in the last quarter. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Oscar Health Trading Down 7.3%

NYSE:OSCR traded down $1.09 during mid-day trading on Wednesday, hitting $13.92. 9,996,630 shares of the company's stock were exchanged, compared to its average volume of 4,349,700. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a fifty-two week low of $11.20 and a fifty-two week high of $23.79. The company has a 50 day simple moving average of $13.73 and a 200-day simple moving average of $14.59. The firm has a market capitalization of $3.49 billion, a P/E ratio of -695.65 and a beta of 1.75.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.83 by $0.09. The firm had revenue of $3 billion during the quarter, compared to analyst estimates of $2.87 billion. Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. The company's revenue was up 42.2% compared to the same quarter last year. During the same quarter last year, the business earned $0.62 EPS. As a group, research analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Wall Street Analyst Weigh In

OSCR has been the topic of a number of research analyst reports. Wells Fargo & Company downgraded shares of Oscar Health from an "overweight" rating to an "equal weight" rating and reduced their price target for the company from $20.00 to $16.00 in a research note on Thursday, March 13th. Wall Street Zen downgraded shares of Oscar Health from a "buy" rating to a "hold" rating in a research report on Thursday, May 22nd. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating, two have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $20.08.

Insider Activity

In other Oscar Health news, Director Elbert O. Jr. Robinson sold 25,000 shares of the business's stock in a transaction on Monday, May 12th. The shares were sold at an average price of $16.43, for a total transaction of $410,750.00. Following the completion of the sale, the director now owns 64,512 shares in the company, valued at approximately $1,059,932.16. The trade was a 27.93% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 24.39% of the stock is currently owned by company insiders.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.